Blood Pressure Transducers Market by Product, by Type and Region, Growth, Trends, Covid-19 Impact, And Forecasts (2022–2030)
Blood Pressure Transducers Market Insights:
A recent analysis by Market Research Community predicted that for blood pressure transducers market will increase from USD 186.5 million in 2021 to USD 360.5 million by 2030.
Using a catheter introduced into the body, low-cost blood pressure transducers are used to measure high blood pressure levels. The medical transducer is mostly used in medical applications and has sensors that convert pressure into a usable output signal.
Due to its ease of use for manual blood pressure monitoring and low risk of human mistake, compared to digital transducers, the aneroid blood pressure transducer is expected to drive the expansion of the technology sector during the projection period. Aneroid blood pressure transducers are growing in popularity due to their wide product availability and affordable alternative to digital transducers.
Europe is expected to witness substantial growth in the forecast period due to the factors such as increased research and development investments, growing technological advancements in medical devices, and rising awareness among people for the treatment of hypertension are the major contributors to the growth of the Blood Pressure Transducers market in the European region.
The market is projected to grow at a significant pace reaching a CAGR of approximately 7.6%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
The study is consolidated into major segments and further into sub-segments, such as by product type (reusable transducers, disposable transducers), by technology (digital, aneroid, and wearable), by end-use (hospitals, ambulatory surgical centers, clinics, diagnostic laboratories), to forecast the market size by blood pressure transducers market value; also includes the analysis of past dynamics from 2016–2021, considering 2021 as the base year.
The report includes a regional analysis and country analysis with the latest trends, along with the major key players including Allergan, Galderma, Merz Pharma, Teoxane Laboratories, Suneva Medical, Sinclair Pharma, Laboratories Vivacy SaS, Cynosure, LLC., Integra LifeSciences, Bioha Laboratories.
Contact: